Loading clinical trials...

MCG for Localization of Tachyarrhythmia's Origin | Clinical Trials | Clareo Health

UNKNOWNNA

MCG for Localization of Tachyarrhythmia's Origin

Magnetocardiography for Precise Identification of the Site of Origin of Tachyarrhythmia

NCT06327425•Qilu Hospital of Shandong University

Summary

This is an exploratory research aiming to accurately identify the site of origin of tachyarrhythmia using Magnetocardiography (MCG), which will have guiding significance for early diagnosis, the formulation of treatment plans and preoperative positioning for radiofrequency ablation.

Eligibility

Age

18 - 79 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age 18-79 years old;
•Those whose conditions are comparatively stable and who have been diagnosed by an attending physician （or physicians with higher qualifications） with paroxysmal supraventricular tachycardia, atrial tachycardia, atrial flutter, atrial fibrillation, or premature ventricular contractions, and who are capable of performing MCG and cardiac electrophysiologic examinations after evaluation.
•Signed informed consent.

Exclusion Criteria

•Those with known structural heart disease such as cardiomyopathy and valvular disease;
•Those with history of other cardiovascular diseases such as pulmonary embolism and aortic dissection;
•Those with connective tissue diseases (lupus erythematosus, rheumatoid arthritis, dermatomyositis, polyarteritis nodosa, etc.) combined with cardiac complications;
•Those with obvious abnormal thyroid function, severe anemia or other blood diseases and other diseases that obviously affect the circulating blood supply;
•Those with Obese (BMI\>30kg/cm2) or underweight (BMI\<18kg/cm2);
•Those with malignant tumors;
•Professional athletes, pregnant or breastfeeding women, alcoholics;
•Those with acute diseases or critical illnesses in other systems, such as acute or severe respiratory diseases, abnormal liver function or renal function, etc.;
•Those with infectious diseases or communicable diseases;
•Those who are unable or fail to perform magnetocardiography due to claustrophobia, physical impairment, etc.;
+1 more criteria

Locations (1)

China, Shandong Qilu Hospital of Shandong University

Jinan, Shandong, China

Key Dates

Start Date

March 14, 2024

Primary Completion Date

December 1, 2024

Completion Date

February 1, 2025

Last Updated

August 21, 2024

Enrollment

1,000

ESTIMATED participants

Conditions

TachyarrhythmiaAtrial FlutterParoxysmal Supraventricular TachycardiaAtrial TachycardiaAtrial FibrillationPremature Ventricular Contraction

Interventions

Magnetocardiography

DEVICE

Contacts

Jiaojiao Pang, Doctor

CONTACT

0086-0531-82165398 jiaojiaopang@126.com

Pericardiotomy in Cardiac Surgery

NCT06486636

Atrial FibrillationAtrial Flutter+1 more

View study

RECRUITINGNA

The Z Stitch Early Bed Rest Assessment Study

NCT06087497

Atrial FibrillationAtrial Flutter+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 21, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

MCG for Localization of Tachyarrhythmia's Origin

Inclusion Criteria

Exclusion Criteria

Pericardiotomy in Cardiac Surgery

The Z Stitch Early Bed Rest Assessment Study

Atrial Fibrillation at the Viennese University Emergency Department

Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter

Efficacy and Safety of a Voltage-Guided Stepwise Strategy for Pulmonary Vein Isolation

Clinical Study on the Efficiency of Rapid Arrhythmia Mapping Using EasyStars™ High Density Mapping Catheter Applications